WHO ICTRP trial
A Phase II, Single Centre, Open-label, Randomized Study to Investigate…
EUCTR2006-003476-35-GB · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2006-003476-35-GB |
|---|---|
| Public title | A Phase II, Single Centre, Open-label, Randomized Study to Investigate Meningococcal Serogroup A, C, W-135 and Y Saccharide Specific B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants |
| Scientific title | A Phase II, Single Centre, Open-label, Randomized Study to Investigate Meningococcal Serogroup A, C, W-135 and Y Saccharide Specific B Cell Response to a Primary and a Booster Course of the Novartis Meningococcal ACWY Conjugate Vaccine in Healthy Infants |
| Primary sponsor | Novartis Vaccines and Diagnostics S.r.l |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Phase | Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no |
| Countries | United Kingdom |
| Conditions | The Novartis Meningococcal A, C, W-135 and Y Vaccine is intended for prevention of meningitidis and/or septicemia caused by Neisseria meningitidis serogroups A, C, W-135 and Y. |
| Interventions | Product Name: Novartis Meningococcal ACWY Conjugate Vaccine Product Code: V59 Pharmaceutical Form: Powder and solvent for suspension for injection |
| Registration date | Mar 28, 2007 |
| Target size | 216 |
| Secondary IDs | V59P16 |
| Registry page | clinicaltrialsregister.eu |
At a glance
- Yes Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: